Video

Targeting Nuclear Hormone Receptors in Castration-Resistant Prostate Cancer Trials Within the PCCC

Name: Targeting Nuclear Hormone Receptors in Castration-Resistant Prostate Cancer Trials Within the PCCC
Uploaded: 2016-06-14T00:00:00+00:00
Description: Dr. Russell Szmulewitz, assistant professor of medicine, discusses whether or not standard drugs are being used appropriately/efficiently and should physicians continue these medicines past progression as done for castration. Dr. Szmulewitz also examines how to target/treat resistant disease.

Overview

Dr. Russell Szmulewitz, assistant professor of medicine, discusses whether or not standard drugs are being used appropriately/efficiently and should physicians continue these medicines past progression as done for castration. Dr. Szmulewitz also examines how to target/treat resistant disease.

Published

June 14, 2016

Created by

Related Presenters

Russell Szmulewitz, MD

Assistant Professor of Medicine

Russell Szmulewitz, MD, is an expert in the treatment and management of prostate, bladder, kidney, and testicular cancers. His clinical focus is on the treatment of patients with advanced prostate cancer, with particular expertise in the ...